Prostate
« Previous EntriesStudy: Demand for expensive prostate cancer treatments on the rise
Friday, March 18th, 2011Prostate cancer is one of the most common cancers in the US. 180,000 American men are diagnosed with prostate cancer every year. As a result, the demand and popularity of prostate cancer treatments with latest technologies is increasing day by day. Not surprisingly, these treatment options come with a hefty price tag. However, the price [...]
Study suggests PSA screening reduces prostate cancer mortality in healthy men
Friday, November 5th, 2010Source: MedWire News
Prostate-specific antigen (PSA) screening reduces the risk for prostate cancer-specific mortality (PCSM) compared with usual care in healthy men, suggest US study results.
In contrast, for men with at least one notable comorbidity, undergoing regular PSA screening does not reduce the risk for PCSM compared with remaining under usual care.
Indeed, among men with no [...]
PSA test at 60 years predicts risk for prostate cancer death by 85
Wednesday, September 15th, 2010Source: MedWire News
The prostate-specific antigen (PSA) levels of 60-year old men can predict the likelihood of death from the disease in the subsequent 25 years, report researchers.
The team says that the association between PSA level and prostate cancer death is stronger than the association between PSA and cancer detectable at biopsy, suggesting that the test’s [...]
Statin users may be less likely to experience prostate cancer recurrence
Wednesday, July 14th, 2010Source: MedWire News
Prostate cancer patients treated with radical prostatectomy (RP) may be less likely to experience disease recurrence after surgery if they use certain cholesterol-lowering drugs, report US researchers.
The study results show that men who took statins had a 30% reduced risk for biochemical recurrence after surgery compared with those who did not.
Stephen Freedland from [...]
Metformin May Improve Ability Of Bicalutamide To Slow Proliferation In Hormone-Resistant Prostate Cancer Cell Lines.
Monday, April 26th, 2010MedPage Today (4/24, Susman) reported that “the commonly prescribed anti-diabetes drug metformin appears to improve the ability of bicalutamide (Casodex), an androgen ablation drug, to slow proliferation in hormone-resistant prostate cancer cell lines,” according to a study presented at the annual meeting of the American Association for Cancer Research. Researchers said [...]
Avodart May Help Lower Prostate Cancer Risk In Men At High Risk.
Thursday, April 1st, 2010Source: DIA Daily
NBC Nightly News (3/31, story 4, 2:20, Bazell) reported, “Drug giant GlaxoSmithKline, which makes Avodart [dutasteride],is asking the FDA to allow sales of the drug for a new use, to reduce cancer risk. The head of” a new “study which was paid for by the company agrees.” Dr. Gerald [...]
Statins May Significantly Reduce Prostate Tumor Inflammation.
Tuesday, February 23rd, 2010HealthDay (2/22, Preidt) reported that “cholesterol-lowering statins significantly reduce prostate tumor inflammation, which may help lower the risk of disease progression,” according to a study published online in the journal Cancer Epidemiology, Biomarkers & Prevention. Investigators “examined tissue samples of prostate tumors from 236 men undergoing prostate cancer surgery.” The [...]
Number, age of relatives with prostate cancer influences men’s prostate cancer risk
Wednesday, February 17th, 2010Source: MedWire News
Study findings confirm that men with multiple first-degree relatives are at increased risk for prostate cancer compared with men with no or few affected relatives.
The research also shows that men whose father and/or brothers were diagnosed with prostate cancer under 65 years old are more likely to develop and die from the disease [...]
Compound found in beer may help prevent prostate cancer
Wednesday, December 9th, 2009The natural compound xanthohumol (XN), which is derived from hops, may help prevent prostate cancer, study findings show.
XN is found in plants, fruits, vegetables, and spices, and has been shown to possess a range of chemopreventive actions including: anti-inflammatory, antioxidant, and anti-estrogenic mechanisms, and growth inhibition in vitroand in vivo.
The compound, a prenylated chalcone, works by blocking [...]
Blood Vessels Might Predict Prostate Cancer Behavior
Wednesday, November 4th, 2009A diagnosis of prostate cancer raises the question for patients and their physicians as to how the tumor will behave. Will it grow quickly and aggressively and require continuous treatment, or slowly, allowing therapy and its risks to be safely delayed?
The answer may lie in the size and shape of the blood vessels that are [...]
